Inactive Provider
This provider's NPI has been deactivated on 05/29/2026. The information on this page is historical and may no longer be current.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,573 | 305 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,069 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $795.67 | 40 | $0 (2024) |
| Insmed, Inc. | $542.24 | 19 | $0 (2024) |
| United Therapeutics Corporation | $541.00 | 20 | $0 (2024) |
| Grifols USA, LLC | $314.51 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $283.35 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $225.23 | 11 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $203.61 | 15 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $193.89 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $176.53 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,076 | 106 | GlaxoSmithKline, LLC. ($444.84) |
| 2023 | $1,230 | 69 | GlaxoSmithKline, LLC. ($378.16) |
| 2022 | $929.75 | 50 | Actelion Pharmaceuticals US, Inc. ($136.49) |
| 2021 | $633.43 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($104.03) |
| 2020 | $126.43 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($67.74) |
| 2019 | $243.24 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($97.97) |
| 2018 | $73.03 | 5 | GlaxoSmithKline, LLC. ($28.10) |
| 2017 | $261.61 | 16 | United Therapeutics Corporation ($86.34) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.22 | General |
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 12/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $1.36 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Pulmonology | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $11.96 | General |
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.11 | General |
| 11/13/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $30.53 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Pulmonology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.28 | General |
| 10/28/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/24/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $12.85 | General |
| Category: Sleep Apnea testing | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.26 | General |
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,409 | 2,916 | $423,070 | $172,815 |
| 2022 | 13 | 2,427 | 2,769 | $415,489 | $174,417 |
| 2021 | 15 | 2,377 | 2,748 | $439,912 | $184,426 |
| 2020 | 16 | 1,340 | 1,842 | $339,092 | $131,320 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 405 | 793 | $169,702 | $75,157 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 383 | 465 | $67,425 | $31,589 | 46.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 184 | 184 | $76,728 | $30,975 | 40.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 171 | 181 | $19,367 | $7,663 | 39.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 164 | 166 | $19,920 | $4,803 | 24.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 151 | 151 | $16,912 | $4,009 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 27 | $7,830 | $3,863 | 49.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 104 | 104 | $8,632 | $3,450 | 40.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 61 | 61 | $6,344 | $2,572 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,316 | $1,604 | 37.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 150 | 154 | $5,746 | $1,465 | 25.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 171 | 175 | $6,900 | $1,428 | 20.7% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 65 | 65 | $2,582 | $1,149 | 44.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 153 | 157 | $5,183 | $1,115 | 21.5% |
| 88738 | Hemoglobin measurement | Office | 2023 | 171 | 181 | $2,534 | $890.52 | 35.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 24 | 27 | $1,917 | $546.00 | 28.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,032 | $538.92 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 439 | 701 | $150,014 | $68,801 | 45.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 208 | 208 | $86,736 | $35,976 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 391 | 443 | $64,235 | $31,315 | 48.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 231 | 236 | $25,076 | $10,308 | 41.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 214 | 221 | $26,332 | $6,523 | 24.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 188 | 194 | $21,728 | $5,159 | 23.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 109 | 109 | $11,178 | $4,519 | 40.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 116 | 117 | $9,711 | $3,931 | 40.5% |
About Dr. Craig Harcup, M.D
Dr. Craig Harcup, M.D is a Pulmonary Disease healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497781793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Craig Harcup, M.D has received a total of $5,573 in payments from pharmaceutical and medical device companies, with $2,076 received in 2024. These payments were reported across 305 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,573).
As a Medicare-enrolled provider, Harcup has provided services to 8,553 Medicare beneficiaries, totaling 10,275 services with total Medicare billing of $662,978. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Sarasota, FL
- Active Since 06/25/2006
- Last Updated 01/21/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1497781793
Products in Payments
- TRELEGY ELLIPTA (Drug) $577.60
- Arikayce (Drug) $542.24
- OFEV (Drug) $475.63
- DUPIXENT (Biological) $377.03
- NUCALA (Biological) $370.34
- Prolastin-C Liquid (Biological) $314.51
- TYVASO (Drug) $279.81
- ORENITRAM (Drug) $203.03
- Adempas (Drug) $193.89
- OPSUMIT (Drug) $135.70
- Fetroja (Drug) $130.83
- XARELTO (Drug) $97.59
- FASENRA (Biological) $97.32
- NUZYRA (Drug) $69.85
- UPTRAVI (Drug) $67.91
- REMODULIN (Drug) $58.16
- TUDORZA PRESSAIR (Drug) $57.23
- WINREVAIR (Biological) $51.68
- AIRSUPRA (Drug) $51.32
- SMARTVEST (Device) $43.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Sarasota
Ryan Dunn, M.d, M.D
Pulmonary Disease — Payments: $42,879
Dr. Darren Hoffberger, D.o, D.O
Pulmonary Disease — Payments: $11,749
Mr. Gregory Ferreira, Md, MD
Pulmonary Disease — Payments: $9,953
Rabih Loutfi, Md, MD
Pulmonary Disease — Payments: $9,068
Dr. Todd Horiuchi, Md, MD
Pulmonary Disease — Payments: $6,301
Kisha Morgan, Md, MD
Pulmonary Disease — Payments: $5,179